Industry Research Reports

Home > Reports > Chemical & Material > Global Tocilizumab Market Research Report 2024

Global Tocilizumab Market Research Report 2024

Industry: Chemical & Material

Published Date: 2024-01-12

Pages: 102 Pages

Report ld: 2203312

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Tocilizumab is a humanized monoclonal antibody resistant against the interleukin-6 receptor (IL-6R). It is an immunosuppressive agent commonly used for the treatment of rheumatoid arthritis (RA) and systemic juvenile idiopathic arthritis.

The global Tocilizumab market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for Tocilizumab is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Tocilizumab is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Tocilizumab include Bio-Rad Laboratories, Bio-Techne, BioVision, Selleck Chemicals, Biorbyt, AbMole, Biosynth Carbosynth, SimSon Pharma and BOC Sciences, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Tocilizumab, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tocilizumab.

MARKET SEGMENTATION

By Company

Bio-Rad Laboratories
Bio-Techne
BioVision
Selleck Chemicals
Biorbyt
AbMole
Biosynth Carbosynth
SimSon Pharma
BOC Sciences
Clearsynth
LifeSpan BioSciences

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%

Segment by Application

Research
Medical

biaoTi REPORT SCOPE

The Tocilizumab market size, estimations, and forecasts are provided in terms of output/shipments (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Tocilizumab market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Tocilizumab manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Tocilizumab manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Production/output, value of Tocilizumab by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 4: Consumption of Tocilizumab in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 10: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Tocilizumab Market Overview

1.1 Product Definition

1.2 Tocilizumab Segment by Type

1.2.1 Global Tocilizumab Market Value Growth Rate Analysis by Type 2023 VS 2030

1.2.2 Min Purity Less Than 98%

1.2.3 Min Purity 98%-99%

1.2.4 Min Purity More Than 99%

1.3 Tocilizumab Segment by Application

1.3.1 Global Tocilizumab Market Value Growth Rate Analysis by Application: 2023 VS 2030

1.3.2 Research

1.3.3 Medical

1.4 Global Market Growth Prospects

1.4.1 Global Tocilizumab Production Value Estimates and Forecasts (2019-2030)

1.4.2 Global Tocilizumab Production Capacity Estimates and Forecasts (2019-2030)

1.4.3 Global Tocilizumab Production Estimates and Forecasts (2019-2030)

1.4.4 Global Tocilizumab Market Average Price Estimates and Forecasts (2019-2030)

1.5 Assumptions and Limitations

2 Market Competition by Manufacturers

2.1 Global Tocilizumab Production Market Share by Manufacturers (2019-2024)

2.2 Global Tocilizumab Production Value Market Share by Manufacturers (2019-2024)

2.3 Global Key Players of Tocilizumab, Industry Ranking, 2022 VS 2023 VS 2024

2.4 Global Tocilizumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.5 Global Tocilizumab Average Price by Manufacturers (2019-2024)

2.6 Global Key Manufacturers of Tocilizumab, Manufacturing Base Distribution and Headquarters

2.7 Global Key Manufacturers of Tocilizumab, Product Offered and Application

2.8 Global Key Manufacturers of Tocilizumab, Date of Enter into This Industry

2.9 Tocilizumab Market Competitive Situation and Trends

2.9.1 Tocilizumab Market Concentration Rate

2.9.2 Global 5 and 10 Largest Tocilizumab Players Market Share by Revenue

2.10 Mergers & Acquisitions, Expansion

3 Tocilizumab Production by Region

3.1 Global Tocilizumab Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030

3.2 Global Tocilizumab Production Value by Region (2019-2030)

3.2.1 Global Tocilizumab Production Value Market Share by Region (2019-2024)

3.2.2 Global Forecasted Production Value of Tocilizumab by Region (2025-2030)

3.3 Global Tocilizumab Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030

3.4 Global Tocilizumab Production by Region (2019-2030)

3.4.1 Global Tocilizumab Production Market Share by Region (2019-2024)

3.4.2 Global Forecasted Production of Tocilizumab by Region (2025-2030)

3.5 Global Tocilizumab Market Price Analysis by Region (2019-2024)

3.6 Global Tocilizumab Production and Value, Year-over-Year Growth

3.6.1 North America Tocilizumab Production Value Estimates and Forecasts (2019-2030)

3.6.2 Europe Tocilizumab Production Value Estimates and Forecasts (2019-2030)

3.6.3 China Tocilizumab Production Value Estimates and Forecasts (2019-2030)

3.6.4 Japan Tocilizumab Production Value Estimates and Forecasts (2019-2030)

3.6.5 India Tocilizumab Production Value Estimates and Forecasts (2019-2030)

4 Tocilizumab Consumption by Region

4.1 Global Tocilizumab Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030

4.2 Global Tocilizumab Consumption by Region (2019-2030)

4.2.1 Global Tocilizumab Consumption by Region (2019-2024)

4.2.2 Global Tocilizumab Forecasted Consumption by Region (2025-2030)

4.3 North America

4.3.1 North America Tocilizumab Consumption Growth Rate by Country: 2019 VS 2023 VS 2030

4.3.2 North America Tocilizumab Consumption by Country (2019-2030)

4.3.3 United States

4.3.4 Canada

4.4 Europe

4.4.1 Europe Tocilizumab Consumption Growth Rate by Country: 2019 VS 2023 VS 2030

4.4.2 Europe Tocilizumab Consumption by Country (2019-2030)

4.4.3 Germany

4.4.4 France

4.4.5 U.K.

4.4.6 Italy

4.4.7 Russia

4.5 Asia Pacific

4.5.1 Asia Pacific Tocilizumab Consumption Growth Rate by Region: 2019 VS 2023 VS 2030

4.5.2 Asia Pacific Tocilizumab Consumption by Region (2019-2030)

4.5.3 China

4.5.4 Japan

4.5.5 South Korea

4.5.6 China Taiwan

4.5.7 Southeast Asia

4.5.8 India

4.6 Latin America, Middle East & Africa

4.6.1 Latin America, Middle East & Africa Tocilizumab Consumption Growth Rate by Country: 2019 VS 2023 VS 2030

4.6.2 Latin America, Middle East & Africa Tocilizumab Consumption by Country (2019-2030)

4.6.3 Mexico

4.6.4 Brazil

4.6.5 Turkey

5 Segment by Type

5.1 Global Tocilizumab Production by Type (2019-2030)

5.1.1 Global Tocilizumab Production by Type (2019-2024)

5.1.2 Global Tocilizumab Production by Type (2025-2030)

5.1.3 Global Tocilizumab Production Market Share by Type (2019-2030)

5.2 Global Tocilizumab Production Value by Type (2019-2030)

5.2.1 Global Tocilizumab Production Value by Type (2019-2024)

5.2.2 Global Tocilizumab Production Value by Type (2025-2030)

5.2.3 Global Tocilizumab Production Value Market Share by Type (2019-2030)

5.3 Global Tocilizumab Price by Type (2019-2030)

6 Segment by Application

6.1 Global Tocilizumab Production by Application (2019-2030)

6.1.1 Global Tocilizumab Production by Application (2019-2024)

6.1.2 Global Tocilizumab Production by Application (2025-2030)

6.1.3 Global Tocilizumab Production Market Share by Application (2019-2030)

6.2 Global Tocilizumab Production Value by Application (2019-2030)

6.2.1 Global Tocilizumab Production Value by Application (2019-2024)

6.2.2 Global Tocilizumab Production Value by Application (2025-2030)

6.2.3 Global Tocilizumab Production Value Market Share by Application (2019-2030)

6.3 Global Tocilizumab Price by Application (2019-2030)

7 Key Companies Profiled

7.1 Bio-Rad Laboratories

7.1.1 Bio-Rad Laboratories Tocilizumab Corporation Information

7.1.2 Bio-Rad Laboratories Tocilizumab Product Portfolio

7.1.3 Bio-Rad Laboratories Tocilizumab Production, Value, Price and Gross Margin (2019-2024)

7.1.4 Bio-Rad Laboratories Main Business and Markets Served

7.1.5 Bio-Rad Laboratories Recent Developments/Updates

7.2 Bio-Techne

7.2.1 Bio-Techne Tocilizumab Corporation Information

7.2.2 Bio-Techne Tocilizumab Product Portfolio

7.2.3 Bio-Techne Tocilizumab Production, Value, Price and Gross Margin (2019-2024)

7.2.4 Bio-Techne Main Business and Markets Served

7.2.5 Bio-Techne Recent Developments/Updates

7.3 BioVision

7.3.1 BioVision Tocilizumab Corporation Information

7.3.2 BioVision Tocilizumab Product Portfolio

7.3.3 BioVision Tocilizumab Production, Value, Price and Gross Margin (2019-2024)

7.3.4 BioVision Main Business and Markets Served

7.3.5 BioVision Recent Developments/Updates

7.4 Selleck Chemicals

7.4.1 Selleck Chemicals Tocilizumab Corporation Information

7.4.2 Selleck Chemicals Tocilizumab Product Portfolio

7.4.3 Selleck Chemicals Tocilizumab Production, Value, Price and Gross Margin (2019-2024)

7.4.4 Selleck Chemicals Main Business and Markets Served

7.4.5 Selleck Chemicals Recent Developments/Updates

7.5 Biorbyt

7.5.1 Biorbyt Tocilizumab Corporation Information

7.5.2 Biorbyt Tocilizumab Product Portfolio

7.5.3 Biorbyt Tocilizumab Production, Value, Price and Gross Margin (2019-2024)

7.5.4 Biorbyt Main Business and Markets Served

7.5.5 Biorbyt Recent Developments/Updates

7.6 AbMole

7.6.1 AbMole Tocilizumab Corporation Information

7.6.2 AbMole Tocilizumab Product Portfolio

7.6.3 AbMole Tocilizumab Production, Value, Price and Gross Margin (2019-2024)

7.6.4 AbMole Main Business and Markets Served

7.6.5 AbMole Recent Developments/Updates

7.7 Biosynth Carbosynth

7.7.1 Biosynth Carbosynth Tocilizumab Corporation Information

7.7.2 Biosynth Carbosynth Tocilizumab Product Portfolio

7.7.3 Biosynth Carbosynth Tocilizumab Production, Value, Price and Gross Margin (2019-2024)

7.7.4 Biosynth Carbosynth Main Business and Markets Served

7.7.5 Biosynth Carbosynth Recent Developments/Updates

7.8 SimSon Pharma

7.8.1 SimSon Pharma Tocilizumab Corporation Information

7.8.2 SimSon Pharma Tocilizumab Product Portfolio

7.8.3 SimSon Pharma Tocilizumab Production, Value, Price and Gross Margin (2019-2024)

7.8.4 SimSon Pharma Main Business and Markets Served

7.7.5 SimSon Pharma Recent Developments/Updates

7.9 BOC Sciences

7.9.1 BOC Sciences Tocilizumab Corporation Information

7.9.2 BOC Sciences Tocilizumab Product Portfolio

7.9.3 BOC Sciences Tocilizumab Production, Value, Price and Gross Margin (2019-2024)

7.9.4 BOC Sciences Main Business and Markets Served

7.9.5 BOC Sciences Recent Developments/Updates

7.10 Clearsynth

7.10.1 Clearsynth Tocilizumab Corporation Information

7.10.2 Clearsynth Tocilizumab Product Portfolio

7.10.3 Clearsynth Tocilizumab Production, Value, Price and Gross Margin (2019-2024)

7.10.4 Clearsynth Main Business and Markets Served

7.10.5 Clearsynth Recent Developments/Updates

7.11 LifeSpan BioSciences

7.11.1 LifeSpan BioSciences Tocilizumab Corporation Information

7.11.2 LifeSpan BioSciences Tocilizumab Product Portfolio

7.11.3 LifeSpan BioSciences Tocilizumab Production, Value, Price and Gross Margin (2019-2024)

7.11.4 LifeSpan BioSciences Main Business and Markets Served

7.11.5 LifeSpan BioSciences Recent Developments/Updates

8 Industry Chain and Sales Channels Analysis

8.1 Tocilizumab Industry Chain Analysis

8.2 Tocilizumab Key Raw Materials

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.3 Tocilizumab Production Mode & Process

8.4 Tocilizumab Sales and Marketing

8.4.1 Tocilizumab Sales Channels

8.4.2 Tocilizumab Distributors

8.5 Tocilizumab Customers

9 Tocilizumab Market Dynamics

9.1 Tocilizumab Industry Trends

9.2 Tocilizumab Market Drivers

9.3 Tocilizumab Market Challenges

9.4 Tocilizumab Market Restraints

10 Research Finding and Conclusion

11 Methodology and Data Source

11.1 Methodology/Research Approach

11.1.1 Research Programs/Design

11.1.2 Market Size Estimation

11.1.3 Market Breakdown and Data Triangulation

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Author List

11.4 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Tocilizumab Market Value by Type, (US$ Million) & (2023 VS 2030)

Table 2. Global Tocilizumab Market Value by Application, (US$ Million) & (2023 VS 2030)

Table 3. Global Tocilizumab Production Capacity (Kg) by Manufacturers in 2023

Table 4. Global Tocilizumab Production by Manufacturers (2019-2024) & (Kg)

Table 5. Global Tocilizumab Production Market Share by Manufacturers (2019-2024)

Table 6. Global Tocilizumab Production Value by Manufacturers (2019-2024) & (US$ Million)

Table 7. Global Tocilizumab Production Value Share by Manufacturers (2019-2024)

Table 8. Global Tocilizumab Industry Ranking 2022 VS 2023 VS 2024

Table 9. Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Tocilizumab as of 2023)

Table 10. Global Market Tocilizumab Average Price by Manufacturers (K USD/Kg) & (2019-2024)

Table 11. Manufacturers Tocilizumab Production Sites and Area Served

Table 12. Manufacturers Tocilizumab Product Types

Table 13. Global Tocilizumab Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Mergers & Acquisitions, Expansion

Table 15. Global Tocilizumab Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 16. Global Tocilizumab Production Value (US$ Million) by Region (2019-2024)

Table 17. Global Tocilizumab Production Value Market Share by Region (2019-2024)

Table 18. Global Tocilizumab Production Value (US$ Million) Forecast by Region (2025-2030)

Table 19. Global Tocilizumab Production Value Market Share Forecast by Region (2025-2030)

Table 20. Global Tocilizumab Production Comparison by Region: 2019 VS 2023 VS 2030 (Kg)

Table 21. Global Tocilizumab Production (Kg) by Region (2019-2024)

Table 22. Global Tocilizumab Production Market Share by Region (2019-2024)

Table 23. Global Tocilizumab Production (Kg) Forecast by Region (2025-2030)

Table 24. Global Tocilizumab Production Market Share Forecast by Region (2025-2030)

Table 25. Global Tocilizumab Market Average Price (K USD/Kg) by Region (2019-2024)

Table 26. Global Tocilizumab Market Average Price (K USD/Kg) by Region (2025-2030)

Table 27. Global Tocilizumab Consumption Growth Rate by Region: 2019 VS 2023 VS 2030 (Kg)

Table 28. Global Tocilizumab Consumption by Region (2019-2024) & (Kg)

Table 29. Global Tocilizumab Consumption Market Share by Region (2019-2024)

Table 30. Global Tocilizumab Forecasted Consumption by Region (2025-2030) & (Kg)

Table 31. Global Tocilizumab Forecasted Consumption Market Share by Region (2019-2024)

Table 32. North America Tocilizumab Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Kg)

Table 33. North America Tocilizumab Consumption by Country (2019-2024) & (Kg)

Table 34. North America Tocilizumab Consumption by Country (2025-2030) & (Kg)

Table 35. Europe Tocilizumab Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Kg)

Table 36. Europe Tocilizumab Consumption by Country (2019-2024) & (Kg)

Table 37. Europe Tocilizumab Consumption by Country (2025-2030) & (Kg)

Table 38. Asia Pacific Tocilizumab Consumption Growth Rate by Region: 2019 VS 2023 VS 2030 (Kg)

Table 39. Asia Pacific Tocilizumab Consumption by Region (2019-2024) & (Kg)

Table 40. Asia Pacific Tocilizumab Consumption by Region (2025-2030) & (Kg)

Table 41. Latin America, Middle East & Africa Tocilizumab Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Kg)

Table 42. Latin America, Middle East & Africa Tocilizumab Consumption by Country (2019-2024) & (Kg)

Table 43. Latin America, Middle East & Africa Tocilizumab Consumption by Country (2025-2030) & (Kg)

Table 44. Global Tocilizumab Production (Kg) by Type (2019-2024)

Table 45. Global Tocilizumab Production (Kg) by Type (2025-2030)

Table 46. Global Tocilizumab Production Market Share by Type (2019-2024)

Table 47. Global Tocilizumab Production Market Share by Type (2025-2030)

Table 48. Global Tocilizumab Production Value (US$ Million) by Type (2019-2024)

Table 49. Global Tocilizumab Production Value (US$ Million) by Type (2025-2030)

Table 50. Global Tocilizumab Production Value Share by Type (2019-2024)

Table 51. Global Tocilizumab Production Value Share by Type (2025-2030)

Table 52. Global Tocilizumab Price (K USD/Kg) by Type (2019-2024)

Table 53. Global Tocilizumab Price (K USD/Kg) by Type (2025-2030)

Table 54. Global Tocilizumab Production (Kg) by Application (2019-2024)

Table 55. Global Tocilizumab Production (Kg) by Application (2025-2030)

Table 56. Global Tocilizumab Production Market Share by Application (2019-2024)

Table 57. Global Tocilizumab Production Market Share by Application (2025-2030)

Table 58. Global Tocilizumab Production Value (US$ Million) by Application (2019-2024)

Table 59. Global Tocilizumab Production Value (US$ Million) by Application (2025-2030)

Table 60. Global Tocilizumab Production Value Share by Application (2019-2024)

Table 61. Global Tocilizumab Production Value Share by Application (2025-2030)

Table 62. Global Tocilizumab Price (K USD/Kg) by Application (2019-2024)

Table 63. Global Tocilizumab Price (K USD/Kg) by Application (2025-2030)

Table 64. Bio-Rad Laboratories Tocilizumab Corporation Information

Table 65. Bio-Rad Laboratories Specification and Application

Table 66. Bio-Rad Laboratories Tocilizumab Production (Kg), Value (US$ Million), Price (K USD/Kg) and Gross Margin (2019-2024)

Table 67. Bio-Rad Laboratories Main Business and Markets Served

Table 68. Bio-Rad Laboratories Recent Developments/Updates

Table 69. Bio-Techne Tocilizumab Corporation Information

Table 70. Bio-Techne Specification and Application

Table 71. Bio-Techne Tocilizumab Production (Kg), Value (US$ Million), Price (K USD/Kg) and Gross Margin (2019-2024)

Table 72. Bio-Techne Main Business and Markets Served

Table 73. Bio-Techne Recent Developments/Updates

Table 74. BioVision Tocilizumab Corporation Information

Table 75. BioVision Specification and Application

Table 76. BioVision Tocilizumab Production (Kg), Value (US$ Million), Price (K USD/Kg) and Gross Margin (2019-2024)

Table 77. BioVision Main Business and Markets Served

Table 78. BioVision Recent Developments/Updates

Table 79. Selleck Chemicals Tocilizumab Corporation Information

Table 80. Selleck Chemicals Specification and Application

Table 81. Selleck Chemicals Tocilizumab Production (Kg), Value (US$ Million), Price (K USD/Kg) and Gross Margin (2019-2024)

Table 82. Selleck Chemicals Main Business and Markets Served

Table 83. Selleck Chemicals Recent Developments/Updates

Table 84. Biorbyt Tocilizumab Corporation Information

Table 85. Biorbyt Specification and Application

Table 86. Biorbyt Tocilizumab Production (Kg), Value (US$ Million), Price (K USD/Kg) and Gross Margin (2019-2024)

Table 87. Biorbyt Main Business and Markets Served

Table 88. Biorbyt Recent Developments/Updates

Table 89. AbMole Tocilizumab Corporation Information

Table 90. AbMole Specification and Application

Table 91. AbMole Tocilizumab Production (Kg), Value (US$ Million), Price (K USD/Kg) and Gross Margin (2019-2024)

Table 92. AbMole Main Business and Markets Served

Table 93. AbMole Recent Developments/Updates

Table 94. Biosynth Carbosynth Tocilizumab Corporation Information

Table 95. Biosynth Carbosynth Specification and Application

Table 96. Biosynth Carbosynth Tocilizumab Production (Kg), Value (US$ Million), Price (K USD/Kg) and Gross Margin (2019-2024)

Table 97. Biosynth Carbosynth Main Business and Markets Served

Table 98. Biosynth Carbosynth Recent Developments/Updates

Table 99. SimSon Pharma Tocilizumab Corporation Information

Table 100. SimSon Pharma Specification and Application

Table 101. SimSon Pharma Tocilizumab Production (Kg), Value (US$ Million), Price (K USD/Kg) and Gross Margin (2019-2024)

Table 102. SimSon Pharma Main Business and Markets Served

Table 103. SimSon Pharma Recent Developments/Updates

Table 104. BOC Sciences Tocilizumab Corporation Information

Table 105. BOC Sciences Specification and Application

Table 106. BOC Sciences Tocilizumab Production (Kg), Value (US$ Million), Price (K USD/Kg) and Gross Margin (2019-2024)

Table 107. BOC Sciences Main Business and Markets Served

Table 108. BOC Sciences Recent Developments/Updates

Table 109. Clearsynth Tocilizumab Corporation Information

Table 110. Clearsynth Specification and Application

Table 111. Clearsynth Tocilizumab Production (Kg), Value (US$ Million), Price (K USD/Kg) and Gross Margin (2019-2024)

Table 112. Clearsynth Main Business and Markets Served

Table 113. Clearsynth Recent Developments/Updates

Table 114. LifeSpan BioSciences Tocilizumab Corporation Information

Table 115. LifeSpan BioSciences Specification and Application

Table 116. LifeSpan BioSciences Tocilizumab Production (Kg), Value (US$ Million), Price (K USD/Kg) and Gross Margin (2019-2024)

Table 117. LifeSpan BioSciences Main Business and Markets Served

Table 118. LifeSpan BioSciences Recent Developments/Updates

Table 119. Key Raw Materials Lists

Table 120. Raw Materials Key Suppliers Lists

Table 121. Tocilizumab Distributors List

Table 122. Tocilizumab Customers List

Table 123. Tocilizumab Market Trends

Table 124. Tocilizumab Market Drivers

Table 125. Tocilizumab Market Challenges

Table 126. Tocilizumab Market Restraints

Table 127. Research Programs/Design for This Report

Table 128. Key Data Information from Secondary Sources

Table 129. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Tocilizumab

Figure 2. Global Tocilizumab Market Value by Type, (US$ Million) & (2023 VS 2030)

Figure 3. Global Tocilizumab Market Share by Type: 2023 VS 2030

Figure 4. Min Purity Less Than 98% Product Picture

Figure 5. Min Purity 98%-99% Product Picture

Figure 6. Min Purity More Than 99% Product Picture

Figure 7. Global Tocilizumab Market Value by Application, (US$ Million) & (2023 VS 2030)

Figure 8. Global Tocilizumab Market Share by Application: 2023 VS 2030

Figure 9. Research

Figure 10. Medical

Figure 11. Global Tocilizumab Production Value (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global Tocilizumab Production Value (US$ Million) & (2019-2030)

Figure 13. Global Tocilizumab Production Capacity (Kg) & (2019-2030)

Figure 14. Global Tocilizumab Production (Kg) & (2019-2030)

Figure 15. Global Tocilizumab Average Price (K USD/Kg) & (2019-2030)

Figure 16. Tocilizumab Report Years Considered

Figure 17. Tocilizumab Production Share by Manufacturers in 2023

Figure 18. Tocilizumab Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 19. The Global 5 and 10 Largest Players: Market Share by Tocilizumab Revenue in 2023

Figure 20. Global Tocilizumab Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Figure 21. Global Tocilizumab Production Value Market Share by Region: 2019 VS 2023 VS 2030

Figure 22. Global Tocilizumab Production Comparison by Region: 2019 VS 2023 VS 2030 (Kg)

Figure 23. Global Tocilizumab Production Market Share by Region: 2019 VS 2023 VS 2030

Figure 24. North America Tocilizumab Production Value (US$ Million) Growth Rate (2019-2030)

Figure 25. Europe Tocilizumab Production Value (US$ Million) Growth Rate (2019-2030)

Figure 26. China Tocilizumab Production Value (US$ Million) Growth Rate (2019-2030)

Figure 27. Japan Tocilizumab Production Value (US$ Million) Growth Rate (2019-2030)

Figure 28. India Tocilizumab Production Value (US$ Million) Growth Rate (2019-2030)

Figure 29. Global Tocilizumab Consumption by Region: 2019 VS 2023 VS 2030 (Kg)

Figure 30. Global Tocilizumab Consumption Market Share by Region: 2019 VS 2023 VS 2030

Figure 31. North America Tocilizumab Consumption and Growth Rate (2019-2024) & (Kg)

Figure 32. North America Tocilizumab Consumption Market Share by Country (2019-2030)

Figure 33. Canada Tocilizumab Consumption and Growth Rate (2019-2024) & (Kg)

Figure 34. U.S. Tocilizumab Consumption and Growth Rate (2019-2024) & (Kg)

Figure 35. Europe Tocilizumab Consumption and Growth Rate (2019-2024) & (Kg)

Figure 36. Europe Tocilizumab Consumption Market Share by Country (2019-2030)

Figure 37. Germany Tocilizumab Consumption and Growth Rate (2019-2024) & (Kg)

Figure 38. France Tocilizumab Consumption and Growth Rate (2019-2024) & (Kg)

Figure 39. U.K. Tocilizumab Consumption and Growth Rate (2019-2024) & (Kg)

Figure 40. Italy Tocilizumab Consumption and Growth Rate (2019-2024) & (Kg)

Figure 41. Russia Tocilizumab Consumption and Growth Rate (2019-2024) & (Kg)

Figure 42. Asia Pacific Tocilizumab Consumption and Growth Rate (2019-2024) & (Kg)

Figure 43. Asia Pacific Tocilizumab Consumption Market Share by Regions (2019-2030)

Figure 44. China Tocilizumab Consumption and Growth Rate (2019-2024) & (Kg)

Figure 45. Japan Tocilizumab Consumption and Growth Rate (2019-2024) & (Kg)

Figure 46. South Korea Tocilizumab Consumption and Growth Rate (2019-2024) & (Kg)

Figure 47. China Taiwan Tocilizumab Consumption and Growth Rate (2019-2024) & (Kg)

Figure 48. Southeast Asia Tocilizumab Consumption and Growth Rate (2019-2024) & (Kg)

Figure 49. India Tocilizumab Consumption and Growth Rate (2019-2024) & (Kg)

Figure 50. Latin America, Middle East & Africa Tocilizumab Consumption and Growth Rate (2019-2024) & (Kg)

Figure 51. Latin America, Middle East & Africa Tocilizumab Consumption Market Share by Country (2019-2030)

Figure 52. Mexico Tocilizumab Consumption and Growth Rate (2019-2024) & (Kg)

Figure 53. Brazil Tocilizumab Consumption and Growth Rate (2019-2024) & (Kg)

Figure 54. Turkey Tocilizumab Consumption and Growth Rate (2019-2024) & (Kg)

Figure 55. GCC Countries Tocilizumab Consumption and Growth Rate (2019-2024) & (Kg)

Figure 56. Global Production Market Share of Tocilizumab by Type (2019-2030)

Figure 57. Global Production Value Market Share of Tocilizumab by Type (2019-2030)

Figure 58. Global Tocilizumab Price (K USD/Kg) by Type (2019-2030)

Figure 59. Global Production Market Share of Tocilizumab by Application (2019-2030)

Figure 60. Global Production Value Market Share of Tocilizumab by Application (2019-2030)

Figure 61. Global Tocilizumab Price (K USD/Kg) by Application (2019-2030)

Figure 62. Tocilizumab Value Chain

Figure 63. Tocilizumab Production Process

Figure 64. Channels of Distribution (Direct Vs Distribution)

Figure 65. Distributors Profiles

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Tocilizumab market? zhanKai

The top companies in the global Tocilizumab market are Bio-Rad Laboratories、Bio-Techne、BioVision.

Related Reports

Tocilizumab- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Tocilizumab was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 140
USD 3950.00
(Single User License)
Global Tocilizumab Market Research Report 2026
The global Tocilizumab market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-21
Pages: 143
USD 2900.00
(Single User License)
Global Tocilizumab Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Tocilizumab market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-22
Pages: 152
USD 4900.00
(Single User License)
Tocilizumab- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Tocilizumab was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 115
USD 3950.00
(Single User License)
Global Tocilizumab Market Research Report 2025
The global market for Tocilizumab was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-15
Pages: 99
USD 2900.00
(Single User License)
Global Tocilizumab Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Tocilizumab market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 93
USD 4250.00
(Single User License)
Global Tocilizumab Market Insights, Forecast to 2030
Tocilizumab is a humanized monoclonal antibody resistant against the interleukin-6 receptor (IL-6R). It is an immunosuppressive agent commonly used for the treatment of rheumatoid arthritis (RA) and systemic juvenile idiopathic arthritis.
Published Date: 2024-04-07
Pages: 105
USD 4900.00
(Single User License)
Tocilizumab - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Tocilizumab is a humanized monoclonal antibody resistant against the interleukin-6 receptor (IL-6R). It is an immunosuppressive agent commonly used for the treatment of rheumatoid arthritis (RA) and systemic juvenile idiopathic arthritis.
Published Date: 2024-02-19
Pages: 121
USD 3950.00
(Single User License)

Tocilizumab- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Tocilizumab was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 140
USD 3950.00 (Single User License)
Global Tocilizumab Market Research Report 2026
The global Tocilizumab market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-21
Pages: 143
USD 2900.00 (Single User License)
Global Tocilizumab Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Tocilizumab market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-22
Pages: 152
USD 4900.00 (Single User License)
Tocilizumab- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Tocilizumab was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 115
USD 3950.00 (Single User License)
Global Tocilizumab Market Research Report 2025
The global market for Tocilizumab was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-15
Pages: 99
USD 2900.00 (Single User License)
Global Tocilizumab Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Tocilizumab market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 93
USD 4250.00 (Single User License)
Global Tocilizumab Market Insights, Forecast to 2030
Tocilizumab is a humanized monoclonal antibody resistant against the interleukin-6 receptor (IL-6R). It is an immunosuppressive agent commonly used for the treatment of rheumatoid arthritis (RA) and systemic juvenile idiopathic arthritis.
Published: 2024-04-07
Pages: 105
USD 4900.00 (Single User License)
Tocilizumab - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Tocilizumab is a humanized monoclonal antibody resistant against the interleukin-6 receptor (IL-6R). It is an immunosuppressive agent commonly used for the treatment of rheumatoid arthritis (RA) and systemic juvenile idiopathic arthritis.
Published: 2024-02-19
Pages: 121
USD 3950.00 (Single User License)